Rudolf Moritz
- Cancer Research top 5%
- MicroRNA in disease regulation 4
- Cancer-related molecular mechanisms research 3
-
- Circular RNAs in diseases 5
-
- Surgical Simulation and Training 2
- Bladder and Urothelial Cancer Treatments 2
- Orthopedic Infections and Treatments 2
-
- Prostate Cancer Diagnosis and Treatment 3
- Prostate Cancer Treatment and Research 3
- Co-authors
- Stefan C. MüllerJörg EllingerStefan HoldenriederEdwin HerrmannGisela Walgenbach‐BrünagelVolker JungCarsten‐Henning OhlmannFrank Becker
- Partner nations
- GermanySwitzerlandAustralia
In The Last Decade
Rudolf Moritz
17 papers receiving 560 citations
Peers
Comparison fields: 5 of 58
- Cancer Research 320
- Molecular Biology 350
- Rheumatology 60
- Urology 23
- Surgery 152
Countries citing papers authored by Rudolf Moritz
This map shows the geographic impact of Rudolf Moritz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rudolf Moritz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rudolf Moritz more than expected).
Fields of papers citing papers by Rudolf Moritz
This network shows the impact of papers produced by Rudolf Moritz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rudolf Moritz. The network helps show where Rudolf Moritz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rudolf Moritz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 7 | |
| 4 | 2022 | 3 | |
| 5 | 2021 | 1 | |
| 6 | 2019 | 34 | |
| 7 | 2015 | 41 | |
| 8 | 2015 | 10 | |
| 9 | 2014 | 1 | |
| 10 | 2014 | 9 | |
| 11 | Serum microRNAs as biomarkers in patients undergoing prostate biopsy: results from a prospective multi-center study. | 2014 | 40 |
| 12 | DNA hypermethylation as a predictor of PSA recurrence in patients with low- and intermediate-grade prostate cancer. | 2013 | 17 |
| 13 | 2012 | 86 | |
| 14 | 2011 | 59 | |
| 15 | 2011 | 199 | |
| 16 | 1999 | 27 | |
| 17 | 1998 | 34 | |
| 18 | [Central nervous and skeletal muscular involvement in Boeck-Besnier-Schaumann's disease]. | 1956 | 1 |
About Rudolf Moritz
Rudolf Moritz is a scholar working on Complementary and Manual Therapy, Cancer Research, Rheumatology, Urology and Physiology, having authored 18 papers that have together received 571 indexed citations. Recurring topics across this work include Circular RNAs in diseases (5 papers), MicroRNA in disease regulation (4 papers), Prostate Cancer Diagnosis and Treatment (3 papers), Cancer-related molecular mechanisms research (3 papers), Prostate Cancer Treatment and Research (3 papers), Surgical Simulation and Training (2 papers), Bladder and Urothelial Cancer Treatments (2 papers) and Orthopedic Infections and Treatments (2 papers). The work is most often cited by research in Cancer Research (320 citations), Molecular Biology (350 citations), Rheumatology (60 citations), Urology (23 citations) and Surgery (152 citations). Rudolf Moritz has collaborated with scholars based in Germany, Switzerland and Australia. Frequent co-authors include Stefan C. Müller, Jörg Ellinger, Stefan Holdenrieder, Edwin Herrmann, Gisela Walgenbach‐Brünagel, Volker Jung, Carsten‐Henning Ohlmann, Frank Becker, Alexander von Ruecker and Glen Kristiansen. Their work appears in journals such as Pediatric Surgery International, PLoS ONE, The Prostate, British Journal of Urology and European Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.